Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Baffr Car-T Cell
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : City of Hope
Deal Size : Inapplicable
Deal Type : Inapplicable
BAFFR-targeting CAR T Cells for Patients with Relapsed or Refractory B-NHL
Details : Baffr Car-T Cell is a Cell and Gene Therapy drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Lymphoma, B-Cell.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Inapplicable
May 11, 2022
Lead Product(s) : Baffr Car-T Cell
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : City of Hope
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Baffr Car-T Cell
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : City of Hope
Deal Size : Inapplicable
Deal Type : Inapplicable
BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL
Details : Baffr Car-T Cell is a Cell and Gene Therapy drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Precursor B-Cell Lymphoblastic Leukemia-Lymphoma.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Inapplicable
December 30, 2020
Lead Product(s) : Baffr Car-T Cell
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : City of Hope
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
